S. Janes (London, United Kingdom), A. Frille (Leipzig, Germany)
Correlation of programmed death-ligand 1(PD-L1) expression in lung cancer between endobronchial ultrasound-guided transbronchial needle aspiration(EBUS-TBNA) samples and histological specimens.
V. Guevara Velazquez (Salamanca, Spain), R. Cordovilla Pérez (Salamanca, Spain), C. Parra (Salamanca, Spain), M. Rodríguez González (Salamanca, Spain), L. Bellido (Salamanca, Spain), R. García García (Salamanca, Spain), M. López Zubizarreta (Avila, Spain), S. Jodra Sánchez (Salamanca, Spain), M. Hernández Mezquita (Salamanca, Spain)
|   |
KPNB1-mediated PD-L1 nuclear translocation promotes non-small cell lung cancer cell proliferation via the Gas6/MerTK signalling pathway
W. Du (Suzhou, China), J. Zhu (Suzhou, China), Y. Zeng (Suzhou, China), Y. Zhang (Suzhou, China), Z. Liu (Suzhou, China), J. Huang (Suzhou, China)
| |
NEUROD1 is highly expressed in extensive disease small cell lung cancer by promoting migration.
K. Tanaka (Fukuoka, Japan), Y. Ikematsu (Fukuoka, Japan), K. Ijichi (Fukuoka, Japan), Y. Yoneshima (Fukuoka, Japan), H. Inoue (Fukuoka, Japan), T. Tagawa (Fukuoka, Japan), Y. Nakanishi (Fukuoka, Japan), I. Okamoto (Fukuoka, Japan)
| |
Alpha1-antitrypsin inhibits staurosporine-induced apoptosis of NSCLC cells
S. Wrenger (Hannover, Germany), N. Schwarz (Hannover, Germany), S. Tumpara (Hannover, Germany), E. Ercetin (Hannover, Germany), T. Welte (Hannover, Germany), S. Janciauskiene (Hannover, Germany)
| |
Genetic polymorphisms of renin-angiotensin system and angiogenic factors in NSCLC progression: discovery and validation studies
M. Pereira Catarata (Coimbra, Portugal), R. Ribeiro (Coimbra, Portugal), A. Pêgo (Coimbra, Portugal), C. Robalo Cordeiro (Coimbra, Portugal), M. Oliveira (Porto, Portugal), R. Medeiros (Porto, Portugal), M. Thomas (Heidelberg, Germany), M. Meister (Heidelberg, Germany), T. Muley (Heidelberg, Germany)
| |
ASCL1 suppress ZFP36L1 expression by regulating miR124-3p expression in lung adenocarcinoma
T. Enokido (Tokyo, Japan), N. Miyashita (Tokyo, Japan), M. Horie (Tokyo, Japan), A. Saito (Tokyo, Japan), T. Nagase (Tokyo, Japan)
| |
The Role Of TGF-ß in Lung Cancer Development in COPD Patients
H. Çelik Tuglu (ISPARTA, Turkey), Ö. Özturk (ISPARTA, Turkey), P. Aslan Kosar (ISPARTA, Turkey), A. Akkaya (ISPARTA, Turkey)
| |
Causal RNA signatures in lung adenocarcinoma
G. Giotopoulou (Munich, Germany), M. Pepe (Munich, Germany), S. Behrend (Munich, Germany), G. Ntaliarda (Patras, Greece), A. Lamort (Munich, Germany), I. Lillis (Patras, Greece), M. Spella (Patras, Greece), G. Stathopoulos (Munich, Germany)
| |
Association between H-RAS T81C genetic polymorphism with non-small cell Lung cancer
Y. Lee (Taichung, Taiwan), C. Shih (Taichung, Taiwan)
| |
SNP Rs11614913 in miR-196a is a risk factor for non-small cell lung cancer in Iranians
N. K.Dezfuli (Tehran, Islamic Republic of Iran), S. D. Alipour (Tehran, Islamic Republic of Iran), S. Seyfi (Tehran, Islamic Republic of Iran), N. Dalil Roofchayee (Tehran, Islamic Republic of Iran), I. M. Adcock (london, United Kingdom), . Mortaz (Tehran, Islamic Republic of Iran)
| |
The upregulation of Osteopontin mediates acquired resistance to EGFR-TKI in NSCLC through Integrin/FAK signaling
Y. Fu (Suzhou, China), Y. Zhang (Suzhou, China), Z. Liu (Suzhou, China), J. Huang (Suzhou, China)
| |
Influence of smoking on gene expression in lung adenocarcinoma
M. Arroyo Varela (Malaga, Spain), E. Salcedo Lobera (Malaga, Spain), R. Larrosa Jiménez (Malaga, Spain), M. Claros Díaz (Malaga, Spain), R. Bautista Moreno (Malaga, Spain)
| |
Cocultured brown or white adipocytes can reduce efficacy of targeted therapy in lung cancer cells
A. Frille (Leipzig, Germany), H. Kuhn (Leipzig, Germany), C. Hänel (Leipzig, Germany), T. Ebert (Leipzig, Germany), H. Seyfarth (Leipzig, Germany), H. Wirtz (Leipzig, Germany)
| |
Evaluate soluble PD-L1 in plasma in advanced stage non-small cell lung cancer patients
N. Pham (Hanoi, Vietnam), Q. Do (Hanoi, Vietnam), T. Ta (Hanoi, Vietnam), D. Nguyen (Hanoi, Vietnam), D. Do (Hanoi, Vietnam)
| |
Triptolide enhances radiosensitivity of lung cancer cells via G2/M arrest and autophage
J. Lee (Seoul, Republic of Korea), M. Park (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea)
| |
Identification of PD-L2 on macrophages in lung cancer milieu- pilot study.
I. Kwiecien (Warsaw, Poland), E. Rutkowska (Warsaw, Poland), M. Polubiec-Kownacka (Warsaw, Poland), P. Rzepecki (Warsaw, Poland), J. Domagala-Kulawik (Warsaw, Poland)
| |
Neprilysin functional genetic polymorphism in NSCLC progression without PD-L1 expression
M. Pereira Catarata (Coimbra, Portugal), R. Ribeiro (Coimbra, Portugal), M. Oliveira (Porto, Portugal), M. Thomas (Heidelberg, Portugal), M. Meister (Heidelberg, Portugal), T. Muley (Heidelberg, Portugal)
| |
Lung Microbiota and Streptococcal enrichment in Central Lung Cancer
J. Vengoechea (Zaragoza, Spain), M. Ponce-Alonso (Madrid, Spain), A. Figueredo (Zaragoza, Spain), E. Mincholé (Zaragoza, Spain), R. Del Campo (Madrid, Spain), S. Bello (Zaragoza, Spain)
| |
Lung Micobiome in Lung Cancer
J. Vengoechea (Zaragoza, Spain), M. Ponce-Alonso (Madrid, Spain), A. Figueredo (Zaragoza, Spain), E. Mincholé (Zaragoza, Spain), R. Del Campo (Madrid, Spain), S. Bello (Zaragoza, Spain)
| |